Preclinical validation of Oncodesign’s first radiotracer prior to human application
17/12/15
Press releases 2015
Oncodesign presents novel LRRK2 inhibitor jointly discovered with Ipsen at the 2015 Neurosciences meeting in Chicago
21/10/15
Oncodesign pursues its strategy of expansion in North America
16/10/15
First half 2015 results: significant improvement alongside R&D intensification
15/09/15